Passer au contenu
Retour à la recherche
Ce marché a expiré.

Hongrie – Médicaments divers – Lejárt szabadalmi védettségű, tételes hatóanyagok

Nemzeti Egészségbiztosítási AlapkezelőHongriePublié le 01 oct. 2026
Délai dépassé

Description

Acquisition of off-patent, active substance-based products for the conclusion of a framework agreement, through an open procedure, in accordance with the Kbt. 105. § (1) a) for sections 1-3 and Kbt. 105. § (2) a) for section 4, with the possibility of extending the active period of the Framework Agreement. The subject of the current procurement procedure (by section) is:

1. Infliximab iv. (OENO: 06053) Base quantity: 16 400 000 mg Option quantity: 8 200 000 mg

2. Pomalidomid (OENO: 06082) Base quantity: 201 600 mg Option quantity: 100 800 mg

3. Bevacizumab (OENO: 06036) Base quantity: 60 000 000 mg Option quantity: 30 000 000 mg

4. Tocilizumab (OENO: 06054) Base quantity: 29 400 000 mg Option quantity: 14 700 000 mg

The AK draws the attention of economic operators to the fact that, pursuant to Kbt. 73. § (1) j), any tender containing a higher total bid price than the following amounts is invalid in all sections:

1. Section: net 4.106.896.200 Ft

2. Section: net 300.959.366 Ft

3. Section: net 6.825.060.000 Ft

4. Section: net 11.852.316.000 Ft

The BT-113 is to be completed for technical reasons, and the AK does not wish to limit the maximum number of participants. The evaluation criterion in all sections is the lowest price, in accordance with the 6. § (3) of the 16/2012. (II.16.) government decree.

Codes CPV

Various medicinal products

Documents et soumission

Résumé AI
Connectez-vous pour un résumé AI

Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.

Marchés similaires